维普中文期刊产品整合服务
331篇 您的检索式:作者名="POGUE J"
    题名 作者 年代 出处 被引量
1Overcoming the limitations of current meta-analysis of randomized controlled trials显示文摘 Yusuf S 1998Lancet1998,351,:1
2Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure:a combined analysis of three trials显示文摘Dagenais GR Pogue J Fox K 2006Lancet2006,368,9535:1
3Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial 显示文摘Mann JF Gerstein HC Pogue J 2001Ann Intern Med2001,134,8:1
4Relationship of electro- cardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients 显示文摘Lonn E Mathew J Pogue J 2003Eur J Cardiovasc Prev Rehabil2003,10,6:1
5Telmisartan, ramipril, or both in patients at high risk for vascular events显示文摘Yusuf S Teo KK Pogue J 2008N Engl J Med2008,358,15:1
6Characteristics andshort-term prognosis of perioperative myocardial infarction inpatients undergoing noncardiac suigery: a cohort study 显示文摘Devereaux PJ Xavier D Pogue J 2011Arm Intern Med2011,154,8:1
7Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain ceils 显示文摘LUKIW W J POGUE A I 2007J Inorg Biochem2007,101,9:1
8Renal insuf- ficiency as a preditor of cardiovascular outcomes and the impact of ramipril~ the HOPE radomized trial显示文摘Mann J F Gerstein H C Pogue J Bosch J Yusuf S 2001Ann Intern Med2001,134,:1
9Vitamin E supplementation and cardiovascular events in high-risk patients:the Heart Outcomes Prevention Evaluation Study Investigators显示文摘Yusuf S Dagenais G Pogue J 2000N Engl J Med2000,342,:1
10Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events ( ACTIVE W) : a randomised controlled trial 显示文摘ACTIVE Writing Group of the ACTIVE Investigators Connolly S Pogue J Hart R 2006Lancet2006,367,9526:1
11Telmisartan, ramipril, or both in patients at high risk for vascular events显示文摘Yusuf S Teo KK Pogue J etal 2008N Engl J Med2008,358,15:1
12Outbreak of col- istin-resistant, carbapenem-resistent Klebsiella pneumoniae in metropolitan Detroit, Michigan 显示文摘Marchaim D Ch opra T Pogue J M 2011Antimicrob Agents Chemother2011,55,2:1
13Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies 显示文摘De Koning L Merchant AT Pogue J 2007Eur Heart J2007,28,7:1
14Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events(ACTIVE W):a randomised controlled trial显示文摘Conaolly SJ Pogue J Hart RG 2006Lancet2006,367,9526:1
15Waist circumference and waist-to-hip ratio as predictors of cardiovascular events:meta-regression analysis of prospective studies显示文摘de Koning L Merchant AT Pogue J 2007Eur Heart J2007,28,7:1
16Effect of clopidogrel added to aspirin in patients with atrial fibrillation显示文摘Connolly SJ Pogue J Hart RG 2009N Engl J Med2009,360,20:1
17Characterization of an NF-κB-regulated,miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells显示文摘Pogue A I Li Y Y Cui J G 2009J Inorg Biochem2009,103,11:1
18Telmisartan, ramipril, or both in patients at high risk for vascular events 显示文摘Yusuf S Teo KK Pogue J 2008N Engl J Med2008,358,15:1
19Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range显示文摘Connolly SJ Pogue J Yusuf S 2008Circulation2008,118,20:1
20Vitamin E supplementation and cardiovascular event in high-risk patients: the heart outcomes prevention evaluation study investigators显示文摘Yusuf S Dagenals G Pogue J 2000N Engl J Med2000,342,:1
返回顶部 每页显示:
共17页 首页 上一页 第1页 下一页 末页 /17 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费